EE9800425A - Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena - Google Patents

Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena

Info

Publication number
EE9800425A
EE9800425A EE9800425A EE9800425A EE9800425A EE 9800425 A EE9800425 A EE 9800425A EE 9800425 A EE9800425 A EE 9800425A EE 9800425 A EE9800425 A EE 9800425A EE 9800425 A EE9800425 A EE 9800425A
Authority
EE
Estonia
Prior art keywords
amino acid
acid derivatives
thrombin inhibitors
novel amino
novel
Prior art date
Application number
EE9800425A
Other languages
English (en)
Estonian (et)
Inventor
Gustafsson David
Nystr�m Jan-Erik
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9800425A publication Critical patent/EE9800425A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9800425A 1996-06-07 1997-06-05 Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena EE9800425A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602263A SE9602263D0 (sv) 1996-06-07 1996-06-07 New amino acid derivatives
PCT/SE1997/000989 WO1997046577A1 (en) 1996-06-07 1997-06-05 New amino acid derivatives and their use as thrombin inhibitors

Publications (1)

Publication Number Publication Date
EE9800425A true EE9800425A (et) 1999-06-15

Family

ID=20402928

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800425A EE9800425A (et) 1996-06-07 1997-06-05 Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena

Country Status (26)

Country Link
US (2) US6255301B1 (pt)
EP (1) EP0910573B1 (pt)
JP (1) JP4237824B2 (pt)
CN (1) CN1129604C (pt)
AR (1) AR008046A1 (pt)
AT (1) ATE231883T1 (pt)
AU (1) AU723420B2 (pt)
BR (1) BR9709560A (pt)
CA (1) CA2255625A1 (pt)
CZ (1) CZ398698A3 (pt)
DE (1) DE69718791T2 (pt)
DK (1) DK0910573T3 (pt)
EE (1) EE9800425A (pt)
ES (1) ES2191840T3 (pt)
HU (1) HUP0002404A3 (pt)
ID (1) ID17016A (pt)
IL (2) IL127325A0 (pt)
IS (1) IS4906A (pt)
NO (1) NO317135B1 (pt)
NZ (1) NZ332964A (pt)
PL (1) PL330482A1 (pt)
SE (1) SE9602263D0 (pt)
SK (1) SK165398A3 (pt)
TR (1) TR199802536T2 (pt)
WO (1) WO1997046577A1 (pt)
ZA (1) ZA974542B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) * 1997-12-05 1997-12-05 Astra Ab New compounds
NZ508005A (en) 1998-04-24 2003-05-30 Dimensional Pharm Inc Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines useful as serine protease inhibitors
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
EP1150996B1 (en) * 1999-01-13 2007-11-21 AstraZeneca AB New amidinobenzylamine derivatives and their use as thrombin inhibitors
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE9902270D0 (sv) * 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) * 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
WO2002014270A1 (en) * 2000-08-16 2002-02-21 Astrazeneca Ab New amidino derivatives and their use as thrombin inhibitors
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
EP2242759B1 (en) 2008-02-06 2012-09-12 AstraZeneca AB Compounds
GB0913342D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab Compounds - 801
KR101181918B1 (ko) * 2010-11-09 2012-09-11 주식회사 세라젬 온열치료기용 상하운동 조절장치
IN2013DE02892A (pt) 2013-09-30 2015-04-03 Council Scient Ind Res
JP6382997B2 (ja) * 2014-02-07 2018-08-29 エクセセーラ ファーマシューティカルズ インコーポレイテッド 治療用化合物および組成物
CN108530297B (zh) * 2017-03-03 2021-09-24 联化科技股份有限公司 2-氯-3-甲基苯甲酸及其中间体的制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
CA1341029C (en) 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897515B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (pt) 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
ZA928581B (en) 1991-11-12 1994-05-06 Lilly Co Eli Antithrombotic agents
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
JPH08501057A (ja) 1992-03-04 1996-02-06 ヂョヂセルクタトー インテーゼット カーエフテー 新規な抗凝結因子ペプチド誘導体及びそれを含有する製薬学的組成物及びその製造方法
TW223629B (pt) 1992-03-06 1994-05-11 Hoffmann La Roche
US5583146A (en) 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
AU675981B2 (en) 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
JPH06340619A (ja) 1993-05-03 1994-12-13 Bristol Myers Squibb Co グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤
US5783563A (en) 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
AU1025795A (en) 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
US5726159A (en) 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
IL112795A (en) 1994-03-04 2001-01-28 Astrazeneca Ab Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them
US5705487A (en) 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5561146A (en) 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
DE4443390A1 (de) 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
CN1173872A (zh) 1995-02-10 1998-02-18 巴斯福股份公司 凝血酶抑制剂
NZ302649A (en) 1995-02-17 2000-01-28 Basf Ag Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof
US5914319A (en) 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
EP0820453A4 (en) 1995-04-04 2001-08-29 Merck & Co Inc THROMBIN INHIBITORS
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TW541316B (en) 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
JPH1095898A (ja) 1996-09-25 1998-04-14 Sumitomo Bakelite Co Ltd 難燃性樹脂組成物およびこれを用いた積層板
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
SE9704543D0 (sv) * 1997-12-05 1997-12-05 Astra Ab New compounds

Also Published As

Publication number Publication date
ID17016A (id) 1997-12-04
NZ332964A (en) 2000-08-25
US20020019371A1 (en) 2002-02-14
ES2191840T3 (es) 2003-09-16
IS4906A (is) 1998-11-25
AR008046A1 (es) 1999-12-09
US6838478B2 (en) 2005-01-04
CN1226895A (zh) 1999-08-25
SK165398A3 (en) 1999-08-06
TR199802536T2 (xx) 1999-03-22
JP2000512631A (ja) 2000-09-26
DK0910573T3 (da) 2003-06-23
US6255301B1 (en) 2001-07-03
HUP0002404A3 (en) 2001-02-28
EP0910573A1 (en) 1999-04-28
CZ398698A3 (cs) 1999-07-14
NO985700L (no) 1999-02-05
CN1129604C (zh) 2003-12-03
CA2255625A1 (en) 1997-12-11
AU723420B2 (en) 2000-08-24
SE9602263D0 (sv) 1996-06-07
PL330482A1 (en) 1999-05-24
ATE231883T1 (de) 2003-02-15
IL127325A (en) 2006-10-31
WO1997046577A1 (en) 1997-12-11
ZA974542B (en) 1997-12-08
JP4237824B2 (ja) 2009-03-11
IL127325A0 (en) 1999-09-22
EP0910573B1 (en) 2003-01-29
DE69718791D1 (de) 2003-03-06
BR9709560A (pt) 1999-08-10
NO985700D0 (no) 1998-12-04
DE69718791T2 (de) 2003-10-23
HUP0002404A2 (hu) 2000-10-28
NO317135B1 (no) 2004-08-23
AU3114097A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
EE9800425A (et) Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
EE9900600A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
DK0934301T3 (da) Aminothiophencarboxylsyreamider og anvendelse deraf som phosphodiesteraseinhibitorer
EE04500B1 (et) Trombiini inhibiitorid, nende saamine ja kasutamine
FI973360A0 (fi) Uusia dipeptidisiä amidiineja trombiininestäjiksi
EE03765B1 (et) Propioonhappe derivaadid ja nende kasutamine
EE200000725A (et) Uued 3-arüülpropaanhappe derivaadid ja nende analoogid
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
IS4504A (is) Tvíhringja þrombín efnahemlar með lítinn sameindaþunga
DK0956294T3 (da) Thrombininhibitorer
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
NO950477D0 (no) Aminosyrederivater
EE03745B1 (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
NO994679D0 (no) Quinolin-2-karboksylsyrederivat og anvendelse derav som eksitatorisk aminosyreantagonist
AU5050198A (en) Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
ATE282629T1 (de) Thrombininhibitoren
EE200000179A (et) 1-oxa, aza ja tianaftaleen-2-1 biseetrid fosfolambaani inhibiitoritena
NZ288940A (en) 4-amino-2-oxo-1-piperidineacetic acid tripeptide derivatives as thrombin inhibitors
NO940997D0 (no) Guanidinyl-substituerte heterocykliske trombin-inhibitorer
SE9504349D0 (sv) New amino acid derivatives
SE9502505D0 (sv) New amino acid derivatives
SE9502487D0 (sv) New amino acid derivatives
SE9502503D0 (sv) New amino acid derivatives